NDAVAGINALAEROSOL
Approved
Dec 1963
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
3/8 — Basic
DELFEN (nonoxynol-9) by Personal Genomics. Approved for contraception. First approved in 1963.
Drug data last refreshed 19h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DELFEN is a nonoxynol-9 vaginal aerosol contraceptive and microbicide approved in 1963 for prevention of pregnancy and HIV infections. It is a spermicidal surfactant that disrupts sperm cell membranes and inactivates enveloped viruses through detergent action. The product represents an older, non-hormonal approach to contraception with dual-indication potential.
LOE Approaching
As a 60+ year old product approaching loss of exclusivity with minimal reported spending, DELFEN likely operates with a lean, defensive brand team focused on legacy market maintenance rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications (1)
Clinical Trials (1)
A Study of Nonoxynol-9 (N-9) and HIV Infection
4,400 enrolled
HIV Infections
Career Relevance
DELFEN offers minimal career advancement opportunity; linked job count is zero, reflecting its legacy status and niche market position. Professionals assigned to this product should view it as a portfolio-sustaining role rather than a growth engine or skill-building opportunity.
Worked on DELFEN at Personal Genomics? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.